12/2
09:02 am
rptx
Halper Sadeh LLC Encourages RPTX, AXTA, BLFY, GDEN Shareholders to Contact the Firm to Discuss Their Rights
Low
Report
Halper Sadeh LLC Encourages RPTX, AXTA, BLFY, GDEN Shareholders to Contact the Firm to Discuss Their Rights
12/2
07:51 am
rptx
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Repare Therapeutics Inc. (Nasdaq – RPTX), Axalta Coating Systems Ltd. (NYSE – AXTA), Blue Foundry Bancorp (Nasdaq – BLFY), Golden Entertainment, Inc (Nasdaq - GDEN)
Low
Report
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Repare Therapeutics Inc. (Nasdaq – RPTX), Axalta Coating Systems Ltd. (NYSE – AXTA), Blue Foundry Bancorp (Nasdaq – BLFY), Golden Entertainment, Inc (Nasdaq - GDEN)
11/28
12:39 pm
rptx
Halper Sadeh LLC Encourages THS, RPTX, AXTA Shareholders to Contact the Firm to Discuss Their Rights
Low
Report
Halper Sadeh LLC Encourages THS, RPTX, AXTA Shareholders to Contact the Firm to Discuss Their Rights
11/27
11:13 pm
rptx
HAPPY THANKSGIVING AND INVESTOR ALERT: The M&A Class Action Firm Continues to Investigate the Merger - RPTX, AXTA, WTG and SEMR
Low
Report
HAPPY THANKSGIVING AND INVESTOR ALERT: The M&A Class Action Firm Continues to Investigate the Merger - RPTX, AXTA, WTG and SEMR
11/27
05:52 pm
rptx
HAPPY THANKSGIVING AND $HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger – RPTX, AXTA, WTG and SEMR
Low
Report
HAPPY THANKSGIVING AND $HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger – RPTX, AXTA, WTG and SEMR
11/20
05:25 pm
rptx
Repare Therapeutics Enters into Support and Voting Agreements with Significant Shareholders for Proposed Transaction with XenoTherapeutics, Inc.
Low
Report
Repare Therapeutics Enters into Support and Voting Agreements with Significant Shareholders for Proposed Transaction with XenoTherapeutics, Inc.
11/18
07:21 am
rptx
Repare Therapeutics (NASDAQ:RPTX) was downgraded by analysts at TD Cowen from a "strong-buy" rating to a "hold" rating.
Low
Report
Repare Therapeutics (NASDAQ:RPTX) was downgraded by analysts at TD Cowen from a "strong-buy" rating to a "hold" rating.
11/17
11:03 am
rptx
Repare Therapeutics (NASDAQ:RPTX) was downgraded by analysts at Cowen Inc to a "hold" rating.
Low
Report
Repare Therapeutics (NASDAQ:RPTX) was downgraded by analysts at Cowen Inc to a "hold" rating.
11/14
10:59 pm
rptx
RPTX Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Repare Therapeutics Inc. is Fair to Shareholders
Low
Report
RPTX Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Repare Therapeutics Inc. is Fair to Shareholders
11/14
07:56 pm
rptx
Shareholder Alert: The Ademi Firm investigates whether Repare Therapeutics Inc. is obtaining a Fair Price for its Public Shareholders
Low
Report
Shareholder Alert: The Ademi Firm investigates whether Repare Therapeutics Inc. is obtaining a Fair Price for its Public Shareholders
11/14
06:20 pm
rptx
Repare Therapeutics Enters into Definitive Agreement to be Acquired by XenoTherapeutics, Inc. [Yahoo! Finance]
Low
Report
Repare Therapeutics Enters into Definitive Agreement to be Acquired by XenoTherapeutics, Inc. [Yahoo! Finance]
11/14
04:44 pm
rptx
Repare Therapeutics Enters into Definitive Agreement to be Acquired by XenoTherapeutics, Inc.
High
Report
Repare Therapeutics Enters into Definitive Agreement to be Acquired by XenoTherapeutics, Inc.
10/27
09:42 am
rptx
Repare Therapeutics (NASDAQ:RPTX) had its price target lowered by analysts at HC Wainwright from $5.00 to $3.00. They now have a "buy" rating on the stock.
Low
Report
Repare Therapeutics (NASDAQ:RPTX) had its price target lowered by analysts at HC Wainwright from $5.00 to $3.00. They now have a "buy" rating on the stock.
10/13
04:21 pm
rptx
Repare Therapeutics to Present Initial Data from Phase 1 LIONS Clinical Trial at 37th AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics [Yahoo! Finance]
Low
Report
Repare Therapeutics to Present Initial Data from Phase 1 LIONS Clinical Trial at 37th AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics [Yahoo! Finance]
10/13
04:05 pm
rptx
Repare Therapeutics to Present Initial Data from Phase 1 LIONS Clinical Trial at 37th AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Low
Report
Repare Therapeutics to Present Initial Data from Phase 1 LIONS Clinical Trial at 37th AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
10/9
06:31 am
rptx
Venture firms pour $101M into a biotech using the brain to fix the immune system [Yahoo! Finance]
Low
Report
Venture firms pour $101M into a biotech using the brain to fix the immune system [Yahoo! Finance]
10/8
07:20 am
rptx
Nilo Therapeutics launches with $101 million Series A financing to advance a new class of medicines targeting neural circuits in immune disease and appoints Kim Seth as Chief Executive Officer [Yahoo! Finance]
Low
Report
Nilo Therapeutics launches with $101 million Series A financing to advance a new class of medicines targeting neural circuits in immune disease and appoints Kim Seth as Chief Executive Officer [Yahoo! Finance]